Cargando…
Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity
Parthenolide exhibits anti-leukaemia activity, whilst its synthetic modification to impart improve drug-like properties, including 1,4-conjugate addition of primary and secondary amines, have previously been used, 1,4-addition of aniline derivatives to parthenolide has not been fully explored. A pro...
Autores principales: | Quy, Alex S., Li, Xingjian, Male, Louise, Stankovic, Tatjana, Agathanggelou, Angelo, Fossey, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695678/ https://www.ncbi.nlm.nih.gov/pubmed/33299257 http://dx.doi.org/10.1016/j.tet.2020.131631 |
Ejemplares similares
-
Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia
por: Li, Xingjian, et al.
Publicado: (2019) -
Synthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agents
por: Ding, Yahui, et al.
Publicado: (2018) -
T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid mice
por: Oldreive, Ceri E., et al.
Publicado: (2015) -
Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives
por: Kwok, Marwan, et al.
Publicado: (2021) -
Correction: Kwok et al. Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives. Cancers 2021, 13, 4681
por: Kwok, Marwan, et al.
Publicado: (2022)